Total Equity - Cartesian Therapeutics Inc (NASDAQ:RNAC) - Alpha Spread

Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 16.54 USD 5.82% Market Closed
Market Cap: 353.6m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cartesian Therapeutics Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
Total Equity
-$101.5m
CAGR 3-Years
-189%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$14.8B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$28.2B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
28%

See Also

What is Cartesian Therapeutics Inc's Total Equity?
Total Equity
-101.5m USD

Based on the financial report for Jun 30, 2024, Cartesian Therapeutics Inc's Total Equity amounts to -101.5m USD.

What is Cartesian Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 3Y
-189%

The average annual Total Equity growth rates for Cartesian Therapeutics Inc have been -189% over the past three years .

Back to Top